Skip to main content

7 in 7 healthcare insights: from Bell Potter’s Healthcare conference in Sorrento

Bell Direct
March 18, 2025

Our Market Analyst, Grady Wulff, recently had the opportunity of attending Bell Potter’s Healthcare Conference in Sorrento, Melbourne, where they engaged in in-depth discussions with seven executives from some of Australia’s most promising emerging healthcare companies.

View the full interviews below:

  1. From the Helm: QBiotics Group Limited General Counsel, Ebru Davidson
  2. From the helm: Clarity Pharmaceuticals (ASX:CU6), Executive Chairperson, Alan Taylor
  3. From the helm: Orthocell Limited (ASX:OCC), CEO & Managing Director, Paul Anderson
  4. From the helm: Neuren Pharmaceuticals (ASX:NEU), Chief Executive Officer, Jon Pilcher
  5. From the helm: EBR Systems (ASX:EBR), CEO & President, John McCutcheon
  6. From the helm: Imugene (ASX:IMU) CEO & Managing Director, Leslie Chong
  7. From the helm: Immutep (ASX:IMM) CEO & Managing Director, Marc Voigt

Bell Global Emerging Companies Fund

Bell Direct
August 23, 2019

June Market Overview

Julia Lee
July 11, 2019

May Market Overview

Julia Lee
May 31, 2019

April Market Overview

Julia Lee
April 29, 2019

Investing in ETFs

Bell Direct
April 17, 2019

March Market Overview

Julia Lee
March 28, 2019

Investing in Alternatives

Julia Lee
March 1, 2019

Margin Lending video

Bell Direct
February 28, 2019

February Market Overview

Julia Lee
February 27, 2019

Market Update

Julia Lee
February 19, 2019

APN Asian REIT Fund

Bell Direct
January 24, 2019